View |
|
DR-XY46476
|
Entecavir
|
Keviran
|
500mcg
|
Film-Coated Tablet
|
Antiviral
|
Korea United Pharm. Inc.
|
Korea
|
Renewal
|
03 January 2019
|
03 January 2029
|
View |
|
DR-XY46485
|
Calcium (as Carbonate) + Cholecalciferol + Cyanocobalamin
|
Metvit Forte
|
600mg/ 400 IU/ 100mcg
|
Film-Coated Tablet
|
Vitamins and Mineral
|
Amherst Laboratories, Inc.
|
Philippines
|
Renewal
|
16 January 2024
|
15 January 2029
|
View |
|
DR-XY46486
|
Calcium (as Carbonate) + Cholecalciferol + Cyanocobalamin
|
Metvit
|
300mg/ 200 IU/ 100mcg
|
Film-Coated Tablet
|
Vitamins and Mineral
|
Amherst Laboratories, Inc.
|
Philippines
|
Renewal
|
08 January 2024
|
15 January 2029
|
View |
|
DR-XY46487
|
Multivitamins + Lecithin (see reverse for formulation)
|
Livovid
|
500mg/ 15mg / 3.3mg/ 3mg/ 3mg/ 3mg / 3mcg
|
Softgel Capsule
|
Vitamins
|
Hovid Berhad
|
Malaysia
|
Renewal
|
15 December 2023
|
15 January 2029
|
View |
|
DR-XY46488
|
Polyethylene Glycol 3350
|
Unbranded
|
3350
|
Powder For Oral Solution
|
Laxative
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
15 January 2019
|
15 January 2029
|
View |
|
DR-XY46490
|
Ascorbic Acid (as Sodium Ascorbate) + Zinc (as Gluconate) + Copper (as Gluconate)
|
Immungold
|
250mg/ 20mg/ 500mcg
|
Film-Coated Tablet
|
Vitamin and Minerals
|
United Laboratories, Inc.
|
Philippines
|
Renewal
|
27 March 2023
|
15 January 2029
|
View |
|
DR-XY46491
|
Ascorbic Acid (as Sodium Ascorbate) + Zinc (as Gluconate) + Copper (as Gluconate)
|
ImmunPro Gold
|
500mg/ 45mg/ 1mg
|
Film-Coated Tablet
|
Vitamin & Minerals
|
United Laboratories, Inc.
|
Philippines
|
Renewal
|
18 January 2024
|
15 January 2029
|
View |
|
DR-XY46492
|
Ascorbic Acid (as Sodium Ascorbate)
|
Unbranded
|
500 mg
|
Capsule
|
Vitamin
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
27 October 2023
|
15 January 2029
|
View |
|
DR-XY46493
|
Alendronic Acid (as Sodium Alendronate)
|
Binosto
|
70mg
|
Effervescent Tablet
|
Antiosteoporotic
|
Swissco Services AG
|
Switzerland
|
Monitored Release
|
30 January 2019
|
30 January 2025
|
View |
|
DR-XY46497
|
Multivitamins + Zinc + Selenium + Lecitihin
|
Vigor-Ace
|
[see reverse]
|
Softgel Capsule
|
Vitamins & Minerals
|
PT. Darya-Varia Laboratoria Tbk
|
Indonesia
|
Renewal
|
17 January 2024
|
21 January 2029
|
View |
|
DR-XY46498
|
Iodine (as Iohexol)
|
Unihexol 300
|
300mg/mL Iodine
|
Solution For Iv Injection
|
Watersoluble, nephrotropic, low osmolar X-ray contrast media
|
Unique Pharmaceutical Laboatories
(A Division of J.B. Chemicals & Pharmaceuticals Ltd.)
|
India
|
Renewal
|
05 February 2024
|
16 January 2029
|
View |
DR-XY46499_PI_01.pdf
|
DR-XY46499
|
Levonorgestrel + Ethinylestradiol
|
Zinnia P
|
150 mcg / 30 mcg
|
Sugar Coated Tablet
|
-
|
Mylan Laboratories Limited
|
India
|
-
|
17 March 2022
|
17 January 2026
|
View |
|
DR-XY46503
|
Polyethylene Glycol + Glycerin + Hypromellose
|
Easy-Drop
|
10mg/2mg/2mg per mL
|
Ophthalmic Solution
|
Ophthalmic Lubricant
|
Hanlim Pharmaceutical Co. Ltd.
|
Korea
|
Renewal
|
29 December 2023
|
01 February 2029
|
View |
|
DR-XY46510
|
Alpha Lipoic Acid + Benfotiamine + Pyridoxine Hydrochloride +
Inositol + Lutein + Folic Acid + Zeaxanthin + Methylcobalamin
|
Nuropat
|
100 mg/100 mg/60 mg/50 mg/6 mg/4 mg/2 mg/1.5 mg
|
Tablet
|
-
|
Corona Remedies Pvt., Ltd.
|
India
|
Automatic Renewal
|
03 March 2021
|
25 January 2026
|
View |
|
DR-XY46512
|
Gentamicin (as Sulfate)
|
Gentamin
|
40mg/mL (80mg/2mL)
|
Solution For Injection (Im/Iv)
|
Antibacterial (Aminoglycosides)
|
Furen Pharmaceutical Group Co., Ltd.
|
China
|
Renewal
|
08 March 2024
|
01 February 2029
|
View |
|
DR-XY46513
|
Aciclovir
|
Zyclor
|
250 mg
|
Lyophilized Powder For Injection
|
Antiviral
|
Furen Pharmaceutical Group Co., Ltd.
|
China
|
Renewal
|
21 March 2024
|
01 February 2029
|
View |
|
DR-XY46515
|
Paracetamol
|
Tempra Forte (Orange Flavor)
|
250 mg/5mL
|
Syrup
|
Analgesic/Antipyretic
|
PT Taisho Pharmaceutical Indonesia Tbk.
|
Indonesia
|
Automatic Renewal (E-AR)
|
02 November 2023
|
15 February 2029
|
View |
|
DR-XY46517
|
Sodium Chloride
|
Nasorinse
|
6.5E-5
|
Saline Solution For Nasal Spray
|
Nasal Decongestant
|
Hizon Laboratories, Inc.
|
Philippines
|
Renewal
|
20 March 2024
|
15 February 2029
|
View |
DR-XY46520_PI_01.pdf
|
DR-XY46520
|
Sofosbuvir + Velpatasvir
|
Epclusa
|
400 mg/100 mg
|
Film-Coated Tablet
|
Antiretroviral
|
Patheon Inc.
|
Canada
|
Initial
|
19 February 2019
|
19 February 2025
|
View |
|
DR-XY46536
|
Eicosapentanoic Acid + Docosahexaenoic Acid (see reverse for formulation)
|
None
|
360 mg/240 mg
|
Softgel Capsule
|
LIPID MODIFYING AGENTS (OMEGA-2 FATTY ACIDS)
|
Healthy Option Corporation
|
Philippines
|
Automatic Renewal
|
08 April 2022
|
21 March 2027
|